Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jonathan González García"'
Autor:
Betel, Del Rosario-García, Gloria Julia, Nazco-Casariego, Juan Luis, Gómez-Sirvent, Rosa, García-Marrero, Dácil, García-Rosado, Ana María, López-Lirola, Juana María, Oramas-Rodríguez, Jonathan, González-García
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(3)
To analyse the effectiveness and safety of daptomycin versus vancomycin on the management catheter-related bloodstream nfections in oncology patients.A retrospective study was carried out including all patients admitted at the Medical Oncology Unit b
Autor:
Betel Del Rosario García, Jonathan González García, Fernando Gutiérrez Nicolás, Iris González García, Ruth Ramos Díaz, Sunil Lakhwani Lakhwani, Ivette Mourani Padrón, María Micaela Viña Romero, Gloria Julia Nazco Casariego
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 29(1)
Introduction The addition of imatinib to the therapeutic arsenal for chronic myeloid leukaemia (CML) has changed the natural course of the disease, in such a way that it is now considered a chronic pathology. However, to achieve therapeutic success,
Autor:
Jonathan González García, Ruth Ramos Díaz, Isaac Ceballos Lenza, Fernando Gutiérrez Nicolás, Ivette Mourani Padrón
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(6)
Introduction Trastuzumab is a monoclonal antibody which could induce the activation of a humoral immune response generating anti-drug antibodies (ADAs). Such response depends of the protein nature and the route of administration (intravenous or subcu
Autor:
Matías Llabres Martinez, José Norberto Batista López, Marta Llanos Muñoz, Ruth Ramos Díaz, Isaac Ceballos Lenza, Josefina Cruz Jurado, Alejandro Jiménez Sosa, María Micaela Viña Romero, Fernando Gutiérrez Nicolás, Gloria Julia Nazco Casariego, Jonathan González García
Publikováno v:
The Annals of pharmacotherapy. 54(8)
Background: Subcutaneous trastuzumab (T-SC) administration does not allow the historical target concentration of 20 µg/mL for efficacy to be reached, from the start of treatment in patients with a body mass index (BMI) >30 kg/m2. Objectives: To anal
Autor:
María Lecuona, Jonathan González-García, María del Mar Alonso Socas, María Antonia Miguel Gómez, Ana Madueño
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 36:498-501
Resumen Introduccion El manejo de las bacteriemias por Klebsiella pneumoniae productora de carbapenemasa del tipo OXA-48 (KPOXA-48) es complicado por las escasas opciones terapeuticas y la elevada mortalidad. El objetivo del estudio fue describir las
Autor:
Jonathan, González-García, Fernando, Gutiérrez-Nicolás, Gloria Julia, Nazco-Casariego, María Micaela, Viña-Romero
Publikováno v:
Farmacia Hospitalaria, Vol 43, Iss 2, Pp 50-52 (2019)
Farmacia Hospitalaria v.43 n.2 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Farmacia Hospitalaria v.43 n.2 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
The present work analyzed the stability of trastuzumab concentrations in blood and plasma samples stored at 4 °C and -20 °C.Blood samples of patients treated with trastuzumab (Herceptin ®) were analyzed. Stability of trastuzumab was analyzed under
Autor:
Isaac Ceballos Lenza, Ruth Ramos Díaz, Matías Llabres Martinez, Jonathan González García, José Norberto Batista López, Gloria Julia Nazco Casariego, Fernando Gutiérrez Nicolás
Publikováno v:
Annals of Pharmacotherapy. 51:976-980
Background: Plasma concentrations of trastuzumab min) of 20 µg/mL after first drug administration, established as therapeutically effective in clinical trials. The secondary objective was to identify the physiological and anthropometric characterist
Autor:
Jonathan González García, Fernando Gutiérrez Nicolás, Gloria Julia Nazco Casariego, Cristina Valcárcel Nazco, Jose Norberto Batista López, Juana Oramas Rodríguez
Publikováno v:
Farmacia Hospitalaria, Vol 41, Iss 1, Pp 3-13 (2017)
Introduction: Lung cancer is the third most frequent neoplastic tumour in Spain, with around 27 000 new cases diagnosed per year; 80-95% of these are non-small-cell cancer (NSCLC), and the majority of cases are diagnosed in advanced stages of the dis
Autor:
Jonathan González García, Ana Madueño, María Lecuona, Jesús Oteo, María José Ramos, Yanet Pedroso, Zaida Diaz
Publikováno v:
American Journal of Infection Control. 45:77-79
Asymptomatic colonization of the gastrointestinal tract by carbapenemase-producing Enterobacteriaceae is an important reservoir for transmission that may precede infection. This prospective, observational, case–control study was designed to identif
Autor:
Jesica Diaz-Vera, Ruth Ramos Díaz, Maria Micaela Viña-Romero, Fernando Gutiérrez-Nicolás, Gloria Julia Nazco-Casariego, Jonathan González García
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522095000
Asparaginase (ASNase) use as a tumour-inhibitor drug has changed completely the natural course of paediatric acute lymphoblastic leukaemia (ALL) in such a way that it represents a paradigm shift in ALL management. ASNase treatment emergence has signi